Protease-activated receptor PAR4 drives cardiac inflammatin in diabetes

被引：0
|
作者：
Fender, A. [1 ]
Stolte, S. [1 ]
Leineweber, K. [1 ]
Kamler, M. [2 ]
Dobrev, D. [1 ]
机构：
[1] Univ Duisburg Essen, Inst Pharmacol, Fac Med, Essen, Germany
[2] Univ Duisburg Essen, Dept Thorac & Cardiovasc Surg, Fac Med, Essen, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2020年 / 393卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
46
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [1] Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy
    Rudinga, Gamariel Rwibasira
    Khan, Ghulam Jilany
    Kong, Yi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (02)
  • [2] PAR4 (Protease-Activated Receptor 4) PARticularly Important 4 Antiplatelet Therapy
    Han, Xu
    Nieman, Marvin T.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (02) : 287 - 289
  • [3] Protease-activated receptor-4 (PAR4): a role as inhibitor of visceral pain and hypersensitivity
    Auge, C.
    Balz-Hara, D.
    Steinhoff, M.
    Vergnolle, N.
    Cenac, N.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2009, 21 (11): : 1189 - +
  • [4] Protease-activated Receptor 1 (PAR1) and PAR4 Heterodimers Are Required for PAR1-enhanced Cleavage of PAR4 by α-Thrombin
    Arachiche, Amal
    Mumaw, Michele M.
    de la Fuente, Maria
    Nieman, Marvin T.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (45) : 32553 - 32562
  • [5] Mapping Human Protease-activated Receptor 4 (PAR4) Homodimer Interface to Transmembrane Helix 4
    de la Fuente, Maria
    Noble, Daniel N.
    Verma, Sheetal
    Nieman, Marvin T.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (13) : 10414 - 10423
  • [6] Protease-activated receptors: PAR4 and counting: how long is the course?
    Hollenberg, MD
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (07) : 271 - 273
  • [7] Protease-activated receptor(PAR)1, PAR2 and PAR4 expressions in esophageal squamous cell carcinoma
    Si-Man LI
    Ping JIANG
    Yang XIANG
    Wei-Wei WANG
    Yue-Chun ZHU
    Wei-Yang FENG
    Shu-De LI
    Guo-Yu YU
    Zoological Research, 2014, 35 (05) : 420 - 425
  • [8] Inhibitors of protease-activated receptor 4 (PAR4): a review of recent patents (2013-2021)
    Yu, Xiangying
    Li, Shanshan
    Zhu, Xiong
    Kong, Yi
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2022, 32 (02) : 153 - 170
  • [9] Discovery of Protease-Activated Receptor 4 (PAR4)-Tethered Ligand Antagonists Using Ultralarge Virtual Screening
    Smith, Shannon T.
    Cassada, Jackson B.
    Von Bredow, Lukas
    Erreger, Kevin
    Webb, Emma M.
    Trombley, Trevor A.
    Kalbfleisch, Jacob J.
    Bender, Brian J.
    Zagol-Ikapitte, Irene
    Kramlinger, Valerie M.
    Bouchard, Jacob L.
    Mitchell, Sidnee G.
    Tretbar, Maik
    Shoichet, Brian K.
    Lindsley, Craig W.
    Meiler, Jens
    Hamm, Heidi E.
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2024, 7 (04) : 1086 - 1100
  • [10] Protease-Activated Receptor-4 (PAR4) Inhibits Pro-Nociceptive Signals and Visceral Hypersensitivity
    Auge, Celine
    Cenac, Nicolas
    Balz-Hara, Daniela
    Vergnolle, Nathalie
    GASTROENTEROLOGY, 2009, 136 (05) : A722 - A722
12345